Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors

被引:38
作者
Donnell, Andrew F. [1 ]
Dollings, Paul J. [1 ]
Butera, John A. [1 ]
Dietrich, Arlene J. [1 ]
Lipinski, Kerri K. [2 ]
Ghavami, Afshin [2 ]
Hirst, Warren D. [2 ]
机构
[1] Pfizer Global Res & Dev, Worldwide Med Chem, Princeton, NJ 08543 USA
[2] Pfizer Global Res & Dev, Neurosci Res Unit, Princeton, NJ 08543 USA
关键词
Selective phosphodiesterase inhibitors; Pyridazino[4,5-b]indolizines; Hit-to-lead; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM; ENHANCEMENT; MEMORY; TARGET;
D O I
10.1016/j.bmcl.2010.02.044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Substituted pyridazino[4,5-b]indolizines were identified as potent and selective PDE4B inhibitors. We describe the structure-activity relationships generated around an HTS hit that led to a series of compounds with low nanomolar affinity for PDE4B and high selectivity over the PDE4D subtype. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2163 / 2167
页数:5
相关论文
共 20 条
[1]   Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use [J].
Bender, Andrew T. ;
Beavo, Joseph A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :488-520
[2]   Improving memory: A role for phosphodiesterases [J].
Blokland, A. ;
Schreiber, R. ;
Prickaerts, J. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) :2511-2523
[3]   AN EFFICIENT SYNTHESIS OF 2-CHLORO-3-CARBOETHOXY OR 2-CHLORO-3-CYANO 4,5-DISUBSTITUTED AND 5-SUBSTITUTED PYRROLES [J].
FOLEY, LH .
TETRAHEDRON LETTERS, 1994, 35 (33) :5989-5992
[4]   Selective phosphodiesterase (PDE)-4 inhibitors a novel approach to treating memory deficit? [J].
Ghavami A. ;
Hirst W.D. ;
Novak T.J. .
Drugs in R&D, 2006, 7 (2) :63-71
[5]   Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors [J].
Giovannoni, Maria P. ;
Cesari, Nicoletta ;
Graziano, Alessia ;
Vergelli, Claudia ;
Biancalani, Claudio ;
Biagini, Pierfrancesco ;
Dal Piaz, Vittorio .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (03) :309-318
[6]   Phosphodiesterase-4 as a therapeutic target [J].
Houslay, MD ;
Schafer, P ;
Zhang, KYJ .
DRUG DISCOVERY TODAY, 2005, 10 (22) :1503-1519
[7]   Preferential inhibition of human phosphodiesterase 4 by ibudilast [J].
Huang, Z ;
Liu, S ;
Zhang, L ;
Salem, M ;
Greig, GM ;
Chan, CC ;
Natsumeda, Y ;
Noguchi, K .
LIFE SCIENCES, 2006, 78 (23) :2663-2668
[8]   Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activity [J].
Kanes, S. J. ;
Tokarczyk, J. ;
Siegel, S. J. ;
Bilker, W. ;
Abel, T. ;
Kelly, M. P. .
NEUROSCIENCE, 2007, 144 (01) :239-246
[9]   Identification of PDE4B Over 4D subtype-selective inhibitors revealing an unprecedented binding mode [J].
Kranz, Michael ;
Wall, Michael ;
Evans, Brian ;
Miah, Afjal ;
Ballantine, Stuart ;
Delves, Chris ;
Dombroski, Brian ;
Gross, Jeffrey ;
Schneck, Jessica ;
Villa, James P. ;
Neu, Margarete ;
Somers, Don O. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (14) :5336-5341
[10]   Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease [J].
McLachlan, Craig S. ;
Chen, Melissa L. ;
Lynex, Clare N. ;
Goh, Denise L. M. ;
Brenner, Sydney ;
Tay, Stacey K. H. .
ARCHIVES OF NEUROLOGY, 2007, 64 (03) :456-457